Global Peripheral Neuropathy Treatment Market 2018-2022
About Peripheral Neuropathy
Peripheral neuropathy is a set of symptoms caused by any damage to the nerves that are away from the brain and spinal cord. Peripheral neuropathy is not a single, homogenous disease, but it is a mix of different clinical presentations, natural histories, and pathology.
Technavio’s analysts forecast the Global Peripheral Neuropathy Treatment Market to grow at a CAGR of 3.5% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the peripheral neuropathy treatment market. To calculate the market size, the report considers the revenue generated by the sale of drugs for the treatment of peripheral neuropathy across the globe.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report - Global Peripheral Neuropathy Treatment Market 2018-2022
Technavio recognizes the following companies as the key players in the global peripheral neuropathy treatment market: Eli Lilly, Johnson & Johnson, Novartis, Pfizer, and TEVA Pharmaceutical Industries.
Commenting on the report, an analyst from Technavio’s team said: “One trend affecting this market is the development of topical patches for neuropathy treatment. Most of the established companies in the global peripheral neurotherapy treatment market are focused on getting involved in the development of topical patches.”
According to the report, one driver influencing this market is the growing awareness about peripheral neuropathy. The growth of the global neurotrophic keratitis market is driven by growing geriatric population which will boost the demand for various types of keratopathy treatment.
Further, the report states that one challenge affecting this market is the complications involved in the diagnosis of peripheral neuropathy. The diagnosis of peripheral neuropathy is very complicated and physicians face challenges due to the heterogenicity of the disease.
Johnson & Johnson
TEVA Pharmaceutical Industries